| [1] |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华肝脏病杂志, 2017, 25(12):886-895.
|
| [2] |
中国抗癌协会肝癌专业委员会，中华医学会肝病学分会肝癌学组，中国抗癌协会病理专业委员会, 等. 原发性肝癌规范化病理诊断指南(2015年版)[J]. 中华肝胆外科杂志, 2015, 21(3):145-151.
|
| [3] |
Feng L, Dong H, Lau W, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2017, 143(2):293-303.
|
| [4] |
蒋亚波，郭卫星，程树群. 肝细胞癌伴门静脉癌栓发生机制的研究进展[J]. 中国细胞生物学学报, 2017, 39(2):244-249.
|
| [5] |
赵晖，陈骏，严笑鹏, 等. 肝细胞癌患者微血管侵犯的组织学风险分级与预后的关系[J]. 中华肝胆外科杂志, 2019, 25(6):401-405.
|
| [6] |
Li J, Yan Z, Gong R, et al. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy[J]. Oncologist, 2012, 17(7):963-969.
|
| [7] |
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis[J]. Ann Surg, 2018, 267(6):1047-1055.
|
| [8] |
Zheng J, Chakraborty J, Chapman WC, et al. Preoperative prediction of microvascular invasion in hepatocellular carcinoma using quantitative image analysis[J]. J Am Coll Surg, 2017, 225(6):778-788, e1.
|
| [9] |
Imura S, Teraoku H, Yoshikawa M, et al. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria[J]. Int J Clin Oncol, 2018, 23(1):98-103.
|
| [10] |
Burt AD, Alves V, Bedossa P, et al. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)[J]. Histopathology, 2018, 73(3):369-385.
|
| [11] |
Rhee H, Chung T, Yoo JE, et al. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression[J]. Hepatol Int, 2020, 14(2):239-248.
|
| [12] |
Renzulli M, Brocchi S, Cucchetti A, et al. Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?[J]. Radiology, 2016, 279(2):432-442.
|
| [13] |
Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria[J]. JAMA Surg, 2016, 151(4): 356-363.
|
| [14] |
Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors[J]. Ann Surg Oncol, 2008, 15(5):1375-1382.
|
| [15] |
刘臻玉，武丹，区锦玲, 等. 肝癌微血管侵犯的特点及相关临床指标[J]. 肝胆胰外科杂志, 2017, 29(2):107-111.
|
| [16] |
Yang F, Ma L, Yang Y, et al. Contribution of hepatitis B virus infection to the aggressiveness of primary liver cancer: a clinical epidemiological study in Eastern China[J]. Front Oncol, 2019(9): 370.
|
| [17] |
Xu J, Liu H, Chen L, et al. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1[J]. Gastroenterology, 2012, 143(1): 199-212, e4.
|
| [18] |
Poté N, Cauchy F, Albuquerque M, et al. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion[J]. J Hepatol, 2015, 62(4):848-854.
|
| [19] |
Ryu T, Takami Y, Wada Y, et al. A clinical scoring system for predicting microvascular invasion in patients with hepatocellular carcinoma within the Milan criteria[J]. J Gastrointest Surg, 2019, 23(4):779-787.
|
| [20] |
童林，高致远，黄晨军, 等. GALAD模型在原发性肝细胞癌诊断及微血管侵犯预测中的作用[J]. 中华检验医学杂志, 2019, 42(12):1037-1041.
|
| [21] |
邹珍珍，王坤，何璐, 等. 异常凝血酶原和甲胎蛋白联合检测在原发性肝癌中的临床价值[J]. 检验医学与临床, 2019, 16(12): 1771-1773.
|
| [22] |
Rungsakulkij N, Mingphruedh S, Suragul W, et al. Platelet-to-lymphocyte ratio and large tumor size predict microvascular invasion after resection for hepatocellular carcinoma[J]. Asian Pac J Cancer Prev, 2018, 19(12):3435-3441.
|
| [23] |
于艳龙，刘中华，史赢, 等. 术前中性粒细胞与淋巴细胞比值和肿瘤相关因素预测肝癌患者微血管浸润[J]. 中华肝胆外科杂志, 2019, 25(2):120-123.
|
| [24] |
杜培源，宋京海，乔江春, 等. 肝细胞癌患者微血管侵犯影响因素分析[J]. 中华肝胆外科杂志, 2019, 25(1):26-29.
|
| [25] |
赵晖，何建，陈闯, 等. 瘤内动脉联合肿瘤形态分型对肝细胞癌微血管侵犯的预测价值[J]. 中华肝胆外科杂志, 2018, 24(2):73-78.
|
| [26] |
Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma[J]. Hepatology, 2015, 62(3): 792-800.
|
| [27] |
Yang C, Zhang S, Jia Y, et al. Dual energy spectral CT imaging for the evaluation of small hepatocellular carcinoma microvascular invasion[J]. Eur J Radiol, 2017(95):222-227.
|
| [28] |
陈培培，陆健，张涛, 等. 钆塞酸二钠增强MRI对肝细胞癌微血管侵犯的预测价值[J]. 中华放射学杂志, 2019, 53(2):103-108.
|
| [29] |
刘连凤，赵盛发，王夺, 等. 超声对肝癌微血管侵犯及术后早期复发的预测价值[J]. 广东医学, 2018, 39(20):3042-3046.
|
| [30] |
Orcutt ST, Anaya DA. Liver resection and surgical strategies for management of primary liver cancer[J]. Cancer Control, 2018, 25(1): 1073274817744621.
|
| [31] |
Han J, Li Z, Xing H, et al. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study[J]. HPB, 2019, 21(8):962-971.
|
| [32] |
Zhao H, Chen C, Fu X, et al. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection[J]. Oncotarget, 2017, 8(3):5474-5486.
|
| [33] |
Zhong X, Zhang Y, Mei J, et al. Anatomical versus non-anatomical resection for hepatocellular carcinoma with microscope vascular invasion: a propensity score matching analysis[J]. J Cancer, 2019, 10(17):3950-3957.
|
| [34] |
Yamashita Y, Tsuijita E, Takeishi K, et al. Predictors for microinvasion of small hepatocellular carcinoma≤2 cm[J]. Ann Surg Oncol, 2012, 19(6):2027-2034.
|
| [35] |
Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer≤2 cm: results from two Western centers[J]. Hepatology, 2013, 57(4):1426-1435.
|
| [36] |
Shi F, Zhou Z, Huang X, et al. Is anatomical resection necessary for early hepatocellular carcinoma? a single institution retrospective experience[J]. Future Oncol, 2019, 15(17):2041-2051.
|
| [37] |
Jung D, Hwang S, Lee Y, et al. Small hepatocellular carcinoma with low tumor marker expression benefits more from anatomical resection than tumors with aggressive biology[J]. Ann Surg, 2019, 269(3):511-519.
|
| [38] |
Zhao H, Chen C, Gu S, et al. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: a propensity score matching analysis[J].J Gastroenterol Hepatol, 2017, 32(4):870-878.
|
| [39] |
Wang L, Wang W, Yao X, et al. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion[J]. Oncotarget, 2017, 8(45):79971-79981.
|
| [40] |
张小晶，王琳. 微血管侵犯在肝癌综合诊断与治疗中的临床意义[J]. 中华消化外科杂志, 2019, 18(4):336-341.
|
| [41] |
Bhangui P, Allard MA, Vibert E, et al. Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes?[J]. Ann Surg, 2016, 264(1):155-163.
|
| [42] |
Viveiros A, Zoller H, Finkenstedt A. Hepatocellular carcinoma: when is liver transplantation oncologically futile?[J]. Transl Gastroenterol Hepatol, 2017(2):63.
|
| [43] |
中国医师协会介入医师分会. 中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J]. 中华肝脏病杂志, 2019, 27(3):172-181.
|
| [44] |
熊超杰，胡杨科，虞哲伟, 等. 术后经导管(肝)动脉栓塞化疗对合并微血管侵犯的肝癌患者预后影响的研究进展[J]. 中华肝胆外科杂志, 2019, 25(8):631-633.
|
| [45] |
Chen Z, Zhang X, Zhou T, et al. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2019, 45(11):2188-2196.
|
| [46] |
张小晶，刘静，刘坤, 等. 微血管侵犯对肝癌肝切除术后预后的影响[J]. 中华消化外科杂志, 2018, 17(5):483-487.
|
| [47] |
Wang H, Du P, Wu M, et al. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion[J]. Hepatobil Surg Nutr, 2018, 7(6):418-428.
|
| [48] |
Wang L, Chen B, Li Z, et al. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis[J]. Onco Targets Ther, 2019(12):1237-1247.
|
| [49] |
Zhang X, Chai Z, Gao Y, et al. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis[J]. HPB, 2019, 21(12):1687-1696.
|
| [50] |
Li Z, Lei Z, Xia Y, et al. Association of preoperative antiviral treatment with incidences of microvascular invasion and early tumor recurrence in hepatitis B virus-related hepatocellular carcinoma[J]. JAMA Surg, 2018, 153(10):e182721.
|